Where Tomorrow’s Discoveries Begin

GLP-1 receptor agonists like Ozempic and Wegovy are revolutionizing obesity and type 2 diabetes care, offering unprecedented weight loss and metabolic control. This article explores their science, real-world impact, and future implications.

## Introduction Type 2 diabetes has emerged as one of the most pressing public health challenges of the 21st century, affecting hundreds of millions of people worldwide. Once considered a disease of adulthood, it is now…